First Time Loading...
Y

Yifan Pharmaceutical Co Ltd
SZSE:002019

Watchlist Manager
Yifan Pharmaceutical Co Ltd
SZSE:002019
Watchlist
Price: 13.89 CNY -0.14% Market Closed
Updated: May 22, 2024

Yifan Pharmaceutical Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yifan Pharmaceutical Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Y
Yifan Pharmaceutical Co Ltd
SZSE:002019
Income from Continuing Operations
-¥812.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income from Continuing Operations
¥3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Income from Continuing Operations
¥3.1B
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income from Continuing Operations
¥4.4B
CAGR 3-Years
-12%
CAGR 5-Years
1%
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income from Continuing Operations
¥4.3B
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Income from Continuing Operations
-¥780.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Yifan Pharmaceutical Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-812.1m CNY

Based on the financial report for Mar 31, 2024, Yifan Pharmaceutical Co Ltd's Income from Continuing Operations amounts to -812.1m CNY.